Skip to content

Apotheek Merkem

Active
Private limited company (pre-2019)founded 2011active for 15 yearsKouterstraat 51, 8650 Houthulst, BelgiumKBO/BCE: BE 0833.440.232
Summary

Apotheek Merkem has been active since 2011 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €692,424 and a net result of €123,122. Equity has been growing by about 10% per year since 2019. Its solvency ranks better than 94% of 12,775 sector peers (NACE 47, financial year 2025). The computed 12-month bankruptcy probability is below 0.1% (very low).

Overview

Official details

Source: KBO
Status
Active since 03-02-2011 Normal situation
Activity
Retail sale of pharmaceutical products NACE 47730and 4 others
Establishment unit
2.195.498.295 8650 Houthulst, since 20-02-2011
Financial year end
30 September
Peppol
Reachable since 06-02-2026

Board and ownership

Board
  • Lozie ElsDirector

Financial position

98 Excellent Checked score 2025
Bankruptcy probabilitywithin 12 months
< 0.1%
Annual accounts to 30-09-2025
Gross margin
€178,669
▲ 7.0%
Turnover
≈ €830,000
estimated
Profit
€123,122
▲ 4.0%
Equity
€692,424
▲ 17.7%
Total assets
€785,691
▲ 15.3%
Staff
0.1 FTE
=
Score breakdownlowers riskLiquidity: current ratio 9.03, cash €218,519Equity €692,424 (88.1% of total assets)Figures for financial year 2025 (filed on 16-04-2026)Founded in 2011Show the evidence

Checked score

Score 2025
98 / 100
Excellent
Probability in this band: under 0.55%
Financially stronger than 83% of micro companies in retail trade (NACE 47)
Financial strength · tick: 2024
Strong
Solvency 100=
equity 88.1% of total assets
Liquidity 85+6
short-term debt 10.1% · cash 27.8%
Profitability 88-2
return on assets 15.7%
Bankruptcy probability within 12 months
< 0.1% Very low
0%0.5%1.5%4%10%≥ 25%

Fewer than 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median 0.6% (40,272 companies, NACE 47, micro)
Last 24 months 12-2024: < 0.1% 01-2025: < 0.1%● unchanged vs 12-2024 02-2025: < 0.1%● unchanged vs 01-2025 03-2025: < 0.1%● unchanged vs 02-2025 04-2025: 0.1%▲ +0.1 percentage points vs 03-2025 05-2025: 0.1%● unchanged vs 04-2025highest value 06-2025: < 0.1%▼ -0.1 percentage points vs 05-2025 07-2025: < 0.1%● unchanged vs 06-2025 08-2025: < 0.1%● unchanged vs 07-2025 09-2025: < 0.1%● unchanged vs 08-2025 10-2025: < 0.1%● unchanged vs 09-2025 11-2025: < 0.1%● unchanged vs 10-2025 12-2025: < 0.1%● unchanged vs 11-2025 01-2026: < 0.1%● unchanged vs 12-2025 02-2026: < 0.1%● unchanged vs 01-2026 03-2026: < 0.1%● unchanged vs 02-2026 04-2026: 0.1%▲ +0.1 percentage points vs 03-2026 05-2026: < 0.1%▼ -0.1 percentage points vs 04-2026 06-2026: < 0.1%● unchanged vs 05-2026 07-2026: < 0.1%● unchanged vs 06-2026 08-2026: < 0.1%● unchanged vs 07-2026 09-2026: < 0.1%● unchanged vs 08-2026lowest value 10-2026: < 0.1%● unchanged vs 09-2026 11-2026: < 0.1%● unchanged vs 10-2026
Credit of up to €65,000 on 30-day terms is acceptable
Liquidity is ample, with a current ratio of 9.03 (7.33 in 2024), above the usual 1.5. Short-term debt is 10.1% and cash 27.8% of total assets. 11.9% of the assets are financed with debt and provisions.
Calculation

The band follows from the bankruptcy probability. 10 more points roughly halve it.

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 47, micro). It does better than 92% of them on solvency, 88% on liquidity, 83% on profitability and 70% on growth.

The bankruptcy probability was computed on 02-11-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Five signals.
lowers riskneutral
lowers risk · Liquidity: current ratio 9.03, cash €218,519
NBB · annual accounts
lowers risk · Equity €692,424 (88.1% of total assets)
NBB · annual accounts
lowers risk · Figures for financial year 2025 (filed on 16-04-2026)
NBB · annual accounts
lowers risk · Founded in 2011
Companies that have existed this long fail less often. How much that weighs depends on the rest of the company's profile.
KBO
neutral · Latest accounts filed on time
The financial year that closed on 30-09-2025 was due by 30-04-2026 and was filed on 13-04-2026, 17 days ahead of the deadline.
NBB · 10 filings
Deviation from the deadline
2025
17 days early
2024
1 day early
2023
1 day early
2022
2 days late
2021
2 days early
2020
20 days late
2019
on the day
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

The company filed its last 7 accounts on average on the deadline day. In the sector (NACE 47), the median for financial year 2024 was on the deadline day, and 47% of those companies filed late.

Searched, nothing found (2)
neutral · Next filing not due yet
The financial year that closed on 30-09-2026 is due by 30-04-2027. Nothing is late today. The company usually files around 29 April (5 of the last 5 accounts filed within 30 days either side of that date).
Companies Code · seven months
Where today falls in the filing period
30-09-2026 year end03-11-2026 today30-04-2027 deadline
neutral · No strike-offs in the KBO publications
That holds for every publication since 2021.
KBO publications

Key points

  • Positive: Higher solvency than 94% of companies in retail tradesector median 36.6% · 12,775 companies 88.1% View
  • Positive: 7 profitable years in a rowprofit 2025: €123,122 7 years View

Recent changes

  1. · Gazette deed Incorporation
All 14 events

Comparable companies

These companies have the same main activity as Apotheek Merkem: retail sale of pharmaceutical products (NACE 47730). They are comparable in size and age: total assets between €704,000 and €884,000, founded between 2008 and 2011.

CompanyTotal assetsGross margin
Apotheek Merkem Houthulst€785,691€178,669
APOTHEEK COPPENS-DERCON Antwerpen€747,309€186,092
APOTHEEK SPRUYT EVERBERG Kortenberg€848,002€180,026
MOERMAN ANN Knokke-Heist€819,356€137,408
APOTHEEK VAN BACKLÉ Wemmel€790,697€199,919
APOTHEEK PICARD Glabbeek€704,351€148,126
Cobra Apotheek Rosselaar Mol€884,462€155,270
Full comparison

Key facts about Apotheek Merkem

What is the company number of Apotheek Merkem?
The company number of Apotheek Merkem is 0833.440.232. The VAT number is the same number with BE in front: BE 0833.440.232.
Where is Apotheek Merkem based?
The registered office is at Kouterstraat 51, 8650 Houthulst.Company details
What does Apotheek Merkem do?
According to the KBO register, the main activity is retail sale of pharmaceutical products (NACE 47730).
What is the legal form of Apotheek Merkem?
The legal form of Apotheek Merkem is Private limited company (pre-2019) (BVBA).
When was Apotheek Merkem founded?
Apotheek Merkem was founded on 03-02-2011.
Is Apotheek Merkem still active?
Yes, Apotheek Merkem is an active enterprise in the KBO register.
How many employees does Apotheek Merkem have?
Apotheek Merkem had an average of 0.1 full-time equivalents in financial year 2025, according to the filed annual accounts.Financials
What is the turnover of Apotheek Merkem?
The turnover in financial year 2025 is ≈ €830,000. This figure is estimated from the gross margin of €178,669 and 51 comparable companies (NACE 477). It probably lies between €570,000 and €1.6m.
Is Apotheek Merkem profitable?
In financial year 2025, Apotheek Merkem made a profit of €123,122.
Where can I find the annual accounts of Apotheek Merkem?
Apotheek Merkem filed 13 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of Apotheek Merkem due?
Apotheek Merkem must file the annual accounts for financial year 2026 by 30-04-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.